Pacientes y visitantes de Renown Health

SALA DE PRENSA DE RENOWN

Últimos comunicados de prensa

Noticias destacadas

Carreras profesionales

Awards & Accreditations

University of Nevada, Reno

Fundación de Renown Health



Recursos de medios

Renown Public Relations Media Icon
Renown Health's Public Relations Team
news@renown.org

Renown Health's public relations team supports media partners in finding experts on diverse health care topics. In addition, we provide information and answer all questions regarding Renown. We look forward to working with you.

Read MoreMedia Resources
  • Medios en el campus

    A los fines de la confidencialidad del paciente, las políticas de Renown Health requieren que los medios de comunicación estén acompañados por el personal de Relaciones Públicas en todo momento.

    El personal de Relaciones Públicas se complacerá en hacer los arreglos necesarios para el estacionamiento, notificará al personal del hospital correspondiente y lo ayudará a encontrar su destino.

     

    Presentaciones/transmisiones en vivo

    Los medios de comunicación pueden realizar reuniones presenciales y transmisiones en vivo en nuestros campus. A fin de proteger la confidencialidad del paciente y la fluidez del paso, un miembro del personal lo ayudará a encontrar la mejor ubicación para su historia.

    Le pedimos que respete nuestra obligación de proteger el bienestar de nuestros pacientes y el derecho legal a la privacidad.

  • Consultas sobre el estado del paciente

    Cumplimos con las reglamentaciones de la Ley de Portabilidad y Responsabilidad de Seguros de Salud de 1996 (Health Insurance Portability and Accountability Act, HIPAA) para todos los pacientes, incluidos los pacientes de interés público. Las reglamentaciones de la HIPAA especifican qué información puede y no puede divulgarse sin la autorización de un paciente.

    Las reglamentaciones de privacidad del paciente solo nos permiten compartir información relacionada con el estado de aquellos pacientes que figuran en nuestro directorio.

    Las consultas de los medios de comunicación requieren que se escriba correctamente el nombre y el apellido del paciente.

     

    Definiciones de “estado” utilizadas por Renown Health

    Al describir el estado de un paciente, solo podemos divulgar los siguientes estados de pacientes:

    Bueno: los signos vitales, como el pulso, la temperatura y la presión arterial, se mantienen estables y dentro de los límites normales. El paciente está consciente, cómodo y no presenta complicaciones.

    Regular: los signos vitales se mantienen estables y dentro de los límites normales. El paciente está consciente y alerta, aunque puede sentirse incómodo o adolorido, y puede tener complicaciones menores.

    Grave: los signos vitales pueden ser inestables o estar fuera de los límites normales. El paciente está gravemente enfermo o lesionado y puede tener complicaciones importantes.

    Crítico: los signos vitales son inestables o están fuera de los límites normales. Existen complicaciones importantes.

    Nota: “Estable” no es un estado.

Comunicados de prensa

Número de resultados encontrados: 29
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Página n.º 3 Navegar a la página siguiente Página 1 de 3
Saltee a 29 resultados encontrados. Página 1 de 3
    • Miércoles, 06 de marzo de 2024

    Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

    Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    • Lunes, 29 de enero de 2024

    Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

    Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    • Viernes, 03 de noviembre de 2023

    Renown Health Recognized for Excellence with ACC Transcatheter Valve Certification

    Renown developed processes to standardize patient care, increase quality measurement The American College of Cardiology has recognized Renown Health for its demonstrated expertise and commitment in treating patients receiving transcatheter valve repair and replacement procedures. Renown Health was awarded Transcatheter Valve Certification in February based on evaluation of the staff’s ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance. The ACC’s Transcatheter Valve Certification is an external review and certification process that pairs with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification. “Renown Health has demonstrated its commitment to providing northern Nevada with excellent heart care,” said Deepak L. Bhatt, MD, MPH, FACC, chair of the ACC Accreditation Management Board. “ACC Accreditation Services is proud to award Renown Health with Transcatheter Valve Certification.” The certification uses established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance metrics to better identify opportunities for improvement. The nationally acclaimed Renown Institute for Heart & Vascular Health provides the region with top-tier cardiovascular care, including 11 cardiovascular specialties, 52 providers and 69,000 patient visits per year. “Renown was the first healthcare system in the region to offer our patients the minimally invasive Transcatheter Aortic Valve Replacement (TAVR) and in 2022 our team performed 128 TAVR procedures, exceeding the national TAVR quality average,” said Dr. Jayson Morgan, FACC, Director of Cardiovascular Services. “This advanced 60-to-90-minute procedure treats aortic stenosis, a progressive disease that affects the aortic valve in the heart. During the procedure, a new valve is inserted within the diseased aortic valve while the heart is still beating.” The ACC offers U.S. and international hospitals like Renown Health access to a comprehensive suite of cardiac accreditation services designed to optimize patient outcomes and improve hospital financial performance. These services are focused on all aspects of cardiac care, including transcatheter valve therapies. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.   About the American College of Cardiology The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at acc.org or follow @ACCinTouch.

    Read More About Renown Health Recognized for Excellence with ACC Transcatheter Valve Certification

    • Miércoles, 01 de noviembre de 2023

    $5 Million Donation to Renown Health Foundation Will Increase Access to Breast Cancer Care in Northern Nevada

    Gift from Jeanne and Raymond Conrad will support development of the Conrad Breast Center in the new Specialty Care Center at Renown South Meadows Medical Center. Renown Health Foundation announced a $5 million gift from local philanthropists Jeanne and Raymond Conrad on Monday, Oct 30. This gift will establish the Conrad Breast Center at the William N. Pennington Cancer Institute at Renown. The center will be housed in the Specialty Care Center at Renown South Meadows Medical Center. The three-story, 121,000 square foot Specialty Care Center being built on the Renown South Meadows Medical Center campus will feature expanded laboratory and diagnostic services, a surgery center and expanded sterile processing department and more. The Conrad Breast Center is the latest addition to the services planned for the Specialty Care Center and will include imaging, infusion and surgery services along with a wellness center. “With a service area of over 100,000 square miles that serves approximately one million people, Renown sees individuals from all walks of life,” said Jeanne Conrad, philanthropist. “My husband Raymond and I share Renown’s vision for a healthy community and establishing advanced care options for even the most difficult-to-treat cancer cases. We all have been impacted by breast cancer in some way which is why we feel honored to create this legacy.” According to the National Cancer Institute, 12.9% of women born in the United States will develop breast cancer at some time during their lives (based on 2015–2017 data). Here in Nevada, the American Cancer Society estimates 2,620 new cases of breast cancer will be diagnosed in 2023 and that 440 Nevadans will die from breast cancer this year. “Renown Health’s mission to provide best-in-class care in our northern Nevada community and beyond is only possible with generous donors like Jeanne and Raymond Conrad,” said Brian Erling, MD, MBA, Renown Health President & CEO. “This gift establishing the Conrad Breast Center within the William N. Pennington Cancer Institute will positively impact lives in our community for years to come. Cancer does not discriminate and Renown strives to create care environments that cater to all individuals. Our goal is to save lives and ensure better outcomes while keeping families together with convenient care options.” During the formal announcement of the Conrad Breast Center on Monday, Oct. 30, Renown patient and breast cancer survivor, Carolyn Dragics, spoke about her experience receiving care at Renown. Carolyn emphasized that staying close to home was a crucial part of her care journey. To continue expanding regional cancer care options and keep locals close to home, Renown Medical Group recently welcomed two distinguished breast surgical oncologists, Colleen O'Kelly Priddy, MD and Michelle K. Chu, MD to the team. As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. “Northern Nevada’s population continues to grow, and Renown is positioning itself to have the appropriate amount of cancer care providers available for everyone who may need it,” said Greg Walaitis, Renown Health Chief Development Officer. “As the region’s largest not-for-profit healthcare system, Renown works tirelessly to provide members of our community with advanced care. This establishing donation from the Conrad family will continue to build Renown’s vision for increasing cancer care options in our region.” “Every day I am inspired by not only the patients we care for who are fighting the good fight against cancer, but also by the donors like the Conrad family who have given us the opportunity to support our patients in their fight,” said Max Coppes, MD, PhD, MBA, Renown Health’s William N. Pennington Cancer Institute Director. The Conrad Breast Center is another step towards the William N. Pennington Cancer Institute’s ultimate goal for our community: establishing an NCI-designated Cancer Center in Reno. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About $5 Million Donation to Renown Health Foundation Will Increase Access to Breast Cancer Care in Northern Nevada

    • Miércoles, 04 de octubre de 2023

    Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

    Renown Medical Group is thrilled to welcome two distinguished breast surgical oncologists, Colleen O'Kelly Priddy, MD and Michelle K. Chu, MD to the team. These highly skilled breast surgeons will solely focus on providing breast care and therefore play a pivotal role in Renown Health’s William N. Pennington Cancer Institute’s commitment to provide subspecialized care to the people living in our community and beyond. Dr. Colleen O'Kelly Priddy is a fellowship-trained, board-certified breast surgical oncologist with an impressive background in breast cancer surgery. Dr. Priddy was born at Washoe Medical Center (which later became Renown Regional Medical Center) and grew up in Susanville, CA before attending Stanford University for her undergraduate studies. She is a graduate of the University of Nevada, Reno School of Medicine. "I am thrilled to return to Reno to help increase access to world-class surgical breast cancer care,” said Dr. Priddy. “My focus is to provide exceptional care, particularly for young people with breast cancer. I am excited to continue my mission here in northern Nevada." Dr. Michelle K. Chu, a board-certified general surgeon, brings her extensive experience in advanced breast cancer treatment to the Renown team. Dr. Chu received her undergraduate degree from the University of Pennsylvania and her medical degree from Western Reserve School of Medicine in Cleveland, OH. Dr. Chu specializes in oncoplastic breast conserving surgery and nipple sparing mastectomies. "I believe in tailoring treatment options to each patient's unique needs,” Dr. Chu said. “Whether it's preserving the natural shape of the breast or supporting the 'Going Flat' movement, our team strives to provide the best possible outcome for every patient." The newest addition to the William N. Pennington Cancer Institute, Renown Breast Surgery Care provides comprehensive breast surgery care at 1500 E. 2nd Street in Reno, adjacent to the Renown Regional Medical Center campus. "Breast cancer accounts for approximately 20% of newly diagnosed cancer cases in Washoe County, with roughly 520 new cases annually, establishing it as the most prevalent cancer type within our community,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “We are proud, as the community’s largest not-for-profit healthcare system, to invest in cancer prevention and early diagnoses, including mammography screening and genetic research. For those diagnosed with breast cancer, Renown now offers two superb breast surgeons specializing in breast preservation surgery, and a breast surgery center providing comprehensive, compassionate care. Our goal is to save women’s lives, save families and ensure better care and better outcomes. This is a major step forward for women’s healthcare and our community.” As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. "Access to expert breast cancer care close to home is crucial, and our dedicated team at Renown Breast Surgery Care will work tirelessly to provide the highest level of care to patients while working closely with our other cancer specialists," said Max Coppes, MD, PhD, MBA, Director, William N. Pennington Institute for Cancer. “With the exceptional expertise of Dr. Colleen O'Kelly Priddy and Dr. Michelle K. Chu, coupled with our state-of-the-art facility; Renown Health is a true partner in the fight against breast cancer in northern Nevada.” "People are increasingly relocating to northern Nevada, and in fact, Washoe County experienced a 2.1% population growth from April 2020 to July 2022. Consequently, although northern Nevada does not exhibit an above-average cancer rate, we are observing a rise in cases at our facilities," said Dr. Lee Schwartzberg, MD, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute. "Renown Health is positioned to meet this growing demand, and we take pride in consistently adding nationally renowned healthcare providers to our team to save the lives of women in northern Nevada. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

    • Friday, Sep 29, 2023

    Renown Health Nationally Recognized for Commitment to Providing High-Quality Stroke Care With Three American Heart Association Recognitions

    The American Heart Association presents Get With The Guidelines®- Stroke Gold Plus awards for proven dedication to ensuring all stroke patients have access to best practices and life-saving care. Renown Health emergency, medical and surgical providers have received three American Heart Association’s Get With The Guidelines® awards. These awards demonstrate commitment to ensuring stroke patients receive the most appropriate treatments according to nationally recognized, research-based guidelines; reducing disabilities and increasing the number of lives saved. Every 40 seconds, someone in the U.S. has a stroke. Los derrames cerebrales son la quinta causa principal de muerte en los EE. UU. y la principal causa de discapacidades en adultos. Studies show patients recover better when providers consistently follow treatment guidelines. Get With The Guidelines puts the expertise of the American Heart Association and American Stroke Association to work for hospitals nationwide, helping ensure patient care is aligned with the latest research and evidence-based guidelines. “A stroke is an extremely serious condition that requires emergent medical treatment. The faster treatment is provided, the lower the risk of brain injury. We are proud of our thousands of physicians, nurses and clinicians who consistently practice exceptional patient care by adhering to the latest treatment guidelines,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “Get With The Guidelines makes it easier for our teams to put proven knowledge and consistent protocols to work on a daily basis, which studies show can help people live longer and better lives.” “As a participant in Get With The Guidelines programs, Renown qualified for the awards by demonstrating that physicians and clinicians across our integrated health system are committed to improving quality care for stroke patients,” said Bill Plauth, MD, MMM, CPE, Chief Medical Officer for Renown Health and Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine. “If you or a loved one is experiencing a stroke, call 911, as you need skilled medical care immediately. Stroke care focuses on helping people recover as much function as possible and return to independent living. The Renown Neurovascular and Stroke Program and Renown Rehabilitation Hospital teams provide expert emergency stroke care and comprehensive neurovascular care and rehabilitation services.” “We are pleased to recognize Renown Health for its commitment to caring for those in their community who need cardiovascular care,” said John Warner, MD, FAHA, past president of the American Heart Association and CEO of The Ohio State University Wexner Medical Center. “Hospitals that follow the American Heart Association’s quality improvement protocols often see improved patient outcomes, fewer readmissions and lower mortality rates – a win for health care systems, families and communities.” “Renown Regional Medical Center is the only designated Comprehensive Stroke Center in northern Nevada,” says Benjamin Pence, DO, Director, Institute for Neurosciences at Renown. “This means that we have the highest level of certification to receive and treat the most complex stroke cases. Our Institute for Neurosciences team is led by the area's top neurologists, and we conduct research studies involving new ways of preventing, diagnosing, and managing neurological disorders. We care for patients suffering from nerve and brain disorders due to stroke, headache, epilepsy, and other acute causes. We also monitor and develop treatment options for patients with memory and movement disorders such as Alzheimer’s, Parkinson's Disease or Multiple Sclerosis.” Renown Health also received the American Heart Association’s Target: Stroke Honor Roll Elite award. To qualify for this recognition, hospitals must meet specific criteria that reduce the time between an eligible patient’s arrival at the hospital (within 60 minutes or less) and treatment for at least 85 percent of applicable patients. “It is an honor to be among the American Heart Association’s Stroke Honor Roll Elite award recipients,” said Bret Frey, MD, president of Northern Nevada Emergency Physicians Care teams at Renown Health. “We adhere to these rigorous guidelines daily and demonstrate our unwavering commitment to ensuring more people in northern Nevada receive leading emergency and trauma care and the gift of extended, healthier lives.” Renown Health also received the American Heart Association’s Target: Type 2 Diabetes Honor Roll - Stroke award. Target: Type 2 Diabetes aims to ensure patients with Type 2 diabetes, who might be at higher risk for complications, receive the most up-to-date, evidence-based care when hospitalized due to stroke. This award is given to hospitals that qualify for the silver level or higher achievement award within the Get With The Guidelines – Stroke program and achieve an overall Diabetes Cardiovascular Initiative Composite Score of more than 80 percent. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown team, visit renown.org/careers. About Get With The Guidelines Get With The Guidelines® is the American Heart Association/American Stroke Association’s hospital-based quality improvement program that provides hospitals with the latest research-based guidelines. Desarrollado con el objetivo de salvar vidas y acelerar la recuperación, Get With The Guidelines ha influido en la vida de más de 12 millones de pacientes desde 2001. For more information, visit heart.org.

    Read More About Renown Health Nationally Recognized for Commitment to Providing High-Quality Stroke Care With Three American Heart Association Recognitions

    • Miércoles, 26 de julio de 2023

    Renown Health Is Nationally Recognized for Its Commitment To Providing High-Quality Heart Failure Care With Three American Heart Failure Recognitions

    Renown Health Cardiology has received the American Heart Association’s Get With The Guidelines® - Heart Failure Gold Plus quality achievement award for its commitment to improving outcomes for patients with heart failure, meaning reduced readmissions and more healthy days at home. The heart care team also received Target: Heart Failure Honor Roll and Target: Type 2 Diabetes Honor Roll. About 6 million U.S. adults are living with heart failure (HF), a number that is expected to increase to more than 8 million by 2030. Despite the name, HF doesn’t mean that the heart has stopped working – it means the heart is having a hard time pumping blood and oxygen throughout the body. While there’s no cure for HF, patients can live a quality life by working with their health care team to create and stick with a plan that may include medication, symptom monitoring and lifestyle changes. The Get With The Guidelines - Heart Failure quality achievement award is earned by hospitals that demonstrate a commitment to treating patients according to the most up-to-date guidelines as outlined by the American Heart Association. Get With The Guidelines puts the expertise of the American Heart Association to work for hospitals nationwide, helping ensure patient care is aligned with the latest research- and evidence-based guidelines. The program aims to increase healthy days at home and reduce hospital readmissions for heart failure patients. “Renown Health is committed to improving patient care by adhering to the latest treatment guidelines,” said Jayson Morgan, MD, Director of Cardiovascular Services at Renown Health. “Get With The Guidelines makes it easier for our teams to put proven knowledge and guidelines to work on a daily basis, which studies show can help patients recover better. The end goal is to ensure more people in northern Nevada can experience longer, healthier lives.” Each year, program participants qualify for the award recognition by demonstrating how their organization has committed to providing quality care for HF patients. In addition to following treatment guidelines, Get With The Guidelines participants also provide education to patients to help them manage their HF at home. “We are pleased to recognize the leaders and teams at Renown Health for a strong commitment to caring for people with heart failure,” said Clyde W. Yancy, MD, MSc, MACC, FAHA, MACP, FHFSA, national chairperson of the American Heart Association Heart Failure systems of care advisory group and chief, division of cardiology at Northwestern University, Feinberg School of Medicine. “Hospitals that participate in Get With The Guidelines quality improvement programs often see better patient outcomes, fewer readmissions and lower mortality rates – a win for health care systems, families and communities.” Renown Health is also recognized on the American Heart Association’s Target: Heart FailureSM Honor Roll. Hospitals on the Honor Roll meet specific criteria that improves medication adherence, provides early follow-up care and coordination and enhances patient education. The goal is to further reduce hospital readmissions and help patients improve their quality of life in managing this chronic condition. Renown Health additionally received the American Heart Association’s Target: Type 2 Diabetes Honor Roll™ award. Target: Type 2 Diabetes aims to ensure patients with Type 2 diabetes, who might be at higher risk for complications, receive the most up-to-date, evidence-based care when hospitalized due to heart disease or stroke. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. Acerca de Get With The Guidelines Get With The Guidelines® es el programa de mejora de calidad hospitalaria de la Asociación Estadounidense del Corazón y la American Stroke Association que proporciona a los hospitales las últimas pautas basadas en la investigación. Desarrollado con el objetivo de salvar vidas y acelerar la recuperación, Get With The Guidelines ha influido en la vida de más de 12 millones de pacientes desde 2001. For more information, visit heart.org.

    Read More About Renown Health Is Nationally Recognized for Its Commitment To Providing High-Quality Heart Failure Care With Three American Heart Failure Recognitions

    • Viernes, 24 de marzo de 2023

    Freenome Adds Renown Health As Partner for The Sanderson Study

    Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers. The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact. Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw. “We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.” Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology. Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1 Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant. “At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.” The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States. “Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.” Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer. For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org. Click here for more information on the Sanderson Study. About Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. About Renown Health’s William N. Pennington Cancer Institute The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About Freenome Adds Renown Health As Partner for The Sanderson Study

    • Lunes, 23 de enero de 2023

    Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

    Recognized as one of the world’s leading breast cancer experts as a 2023 Legends in Cancer Honoree Dr. Lee Schwartzberg, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown, was honored as the 2023 Legends in Cancer honoree at this year's Best of Breast conference for his contributions to the field of breast cancer. The conference took place on Jan. 21 and 22. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates across the country, and here in Washoe County have declined progressively due to advancements in treatment, detection, and care. Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. Here in Washoe County, more than 21 deaths per 100,000 females are due to breast cancer, a significant decrease since 2012 when 24 deaths per 100,000 females were reported. Dr. Schwartzberg was selected for this award based on his unique and vast contributions to advancing science and patient care, including his major research interests such as therapeutic approaches to breast cancer, targeted therapies, and supportive care. The selection committee evaluates each candidates’ body of work — including contributions to the field of breast cancer in clinical research, patient care, mentoring and community service — before deciding on an honoree. “Dr. Schwartzberg is deserving of this honor. As a national expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is transforming cancer care and improving the lives of all of us in northern Nevada. As the most preferred cancer program in the region, we are working with the support of donors like The William N. Pennington Foundation to recruit additional oncology specialists and cancer science researchers to become the first National Cancer Institute-designated comprehensive cancer care center in Nevada," said Dr. Brian Erling, MBA, CEO of Renown Health. “The incredible care that comes from the William N. Pennington Cancer Institute is possible because of nationally recognized oncologists like Dr. Schwartzberg.” “Dr. Schwartzberg completed fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in New York, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee,” add Paul J. Hauptman, MD, dean of the University of Nevada, Reno School of Medicine and chief academic officer for Renown Health. “We are proud that he serves as a professor of clinical medicine at the University of Nevada, Reno School of Medicine. His research interests include supportive care, precision medicine and patient-reported outcomes in breast cancer and he has published over 300 peer-reviewed manuscripts, book chapters and monographs.” “It is an honor to work with Dr. Schwartzberg and his patients have the most incredible things to say about the care he provides.” said Dr. Max J Coppes, PhD, MBA, Director, William N. Pennington Cancer Institute, Renown Health. “He understands that his patients are going through one of the most challenging times in their lives. Dr. Schwartzberg brings decades of experience to our community, is a great listener, and treats everyone with compassion and dignity. We are so proud to have him at Renown.” The Best of Breast Conference is an innovative medical education program that gathers the world's leading breast cancer experts to discuss cases with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care and survivorship and recurrence — all while incorporating data from the major oncologic annual meetings. Dr. Schwartzberg has been selected to chair Total Health’s spring oncology education retreat in Lake Tahoe on April 15 and 16. The event’s comprehensive agenda will allow attendees to engage with the latest research and strategies in cancer care while networking with colleagues from across the country in a peaceful setting. Additional conference information is available here. Se recomienda que las mujeres se realicen exámenes con mamografía después de los 40 años. For those age 75 and older, a mammogram is recommended every year. Having regular mammograms can lower the risk of dying from breast cancer. Both 3-D digital mammography and whole breast ultrasounds are available at the Greenberg Breast Health Center at Renown and other locations across northern Nevada. The Affordable Care Act makes breast cancer screening and counseling free. All health plans must cover these benefits at no cost to you. Renown MyChart app users can self-schedule a mammogram appointment. To call to schedule, dial 775-982-8100. At the William N. Pennington Cancer Institute at Renown Health, patients receive innovative, personalized treatment to fight cancer while an experienced team provides the support and technology to maintain the highest quality of life. The Renown team’s clinical expertise and advanced treatment options blend evidence-based care with leading-edge research to improve cancer outcomes for every patient and family. For more information or a referral, visit renown.org/cancer. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About Total Health Total Health is a medical information company of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, virtual and in-person. Total Health believes knowledge is power. Its mission is to give oncology healthcare providers an educational experience that equips them with the latest strategies to improve clinical practice and treatment outcomes.

    Read More About Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

    • Jueves, 03 de noviembre de 2022

    Expertos líderes se reúnen en Tahoe para centrarse en los avances científicos y la prevención de las enfermedades cardiovasculares, la primera causa de muerte a nivel mundial.

    Three-day medical education conference advances research, education, prevention and treatment. Physicians and medical professionals from across the country will convene in Lake Tahoe from Friday, Nov. 4 to Sunday, Nov. 6 to explore the most recent advances and established guidelines for the diagnosis, treatment and prevention of cardiovascular disease, diabetes mellitus, stroke and diseases or problems associated with heart disease. Hosted by Renown's Institute for Heart & Vascular Health and the Nevada Academy of Family Physicians, the 32nd annual three-day Trends in Cardiovascular Medicine conference will bring together national experts to explore challenges and solutions to cardiovascular diseases, the leading cause of death globally, taking an estimated 17.9 million lives each year. "The driving force behind this collaborative event is the shared missions of all our organizations, across the country, to advance progress in cardiovascular research, education, prevention and treatment," says Jayson Morgan, MD, FACC, Director of Cardiovascular Services at Renown. "We will be joined by colleagues from across the country including Mayo Clinic College of Medicine and Science in Rochester, UC San Francisco School of Medicine, David Geffen School of Medicine at UCLA, University of Washington Medical Center, University of Chicago Medicine and locally- with experts from Renown's Institute for Heart & Vascular Health/UNR Med and Northern Surgical Associates - to discuss contemporary trends in providing excellent cardiovascular care and prevention." New research will be presented each day from experts across the country, including the following topics: “What the Fentanyl? Making Sense of a Deadly Epidemic” “COVID-19: Return to Sport or Strenuous Activity Following Infection” “Management of Type 2 Diabetes: Evolving Data, Evolving Guidelines, Evolving Practice” “Coronary Microvascular Disease in Women: Signs, Symptoms, Evaluation and Treatment” “Lipoprotein (a): A Risk Factor for Atherosclerosis and an Emerging Therapeutic Target” “Gut Feeling: The Increased Importance of GLP-1 Therapies for Personalized Obesity Management” "Primary Care Perspectives: Peripheral Vascular Disease” “Prevention of Atrial Fibrillation and Sudden Cardiac Death in Women” “Clinical Practice Guidelines for the Management of Heart Failure in 2022: What Do I as a Primary Care Provider Need to Know?” “Can a Patient be Low Risk without a Calcium Score?” “Obesity & Cardiovascular Disease Risk Reduction: How Does Bariatric Surgery Change the Landscape?” To make an appointment with a provider at Renown's Institute for Heart and Vascular Health, request that your primary care provider make a referral. For more information on Renown's Institute for Heart and Vascular Health, visit renown.org/Health-Services/Heart-Care. About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®.

    Read More About Leading Experts Convene in Tahoe To Focus On Scientific Advancements And The Prevention Of Cardiovascular Disease, The #1 Cause Of Death Globally

    • Jueves, 20 de octubre de 2022

    Nationally Recognized Vascular Surgeons Join Renown Health

    Two vascular surgeons bring a quarter of a century of experience to patients and community. As part of a continuing focus to bring comprehensive care to patients experiencing cardiac and vascular disease across northern Nevada, Renown Health Department of Surgery and Renown Institute for Heart & Vascular announce that vascular surgeons, John C. Hansen, MD, FACS and Benjamin P. Jaquish, MD, FACS have joined Renown Health.  "Recognizing the significance of preventing, diagnosing and caring for people with heart and vascular disease, which continues to be on the rise and taking far too many lives, is of critical important to us at Renown," says Christos A. Galanopoulos, MD, MBA, MSc, FACS, VP, Chairman Department of Surgery at Renown Health. "Both Drs. Hansen and Jaquish are superb clinicians, skilled investigators, and effective educators. We are fortunate to have them helping to lead the growth of both the department and the Division of Vascular and Endovascular Surgery." Together, the vascular surgeons have more than 26 years of combined experience caring for northern Nevadans. Dr. Hansen has 20 years of experience in northern Nevada. He is a clinical associate professor of surgery at the University of Nevada, Reno School of Medicine (UNR Med) and currently serves as medical director of vascular and endovascular surgery for Renown Regional Medical Center. "Since 2002, Dr. Hansen has led our region with his expertise and knowledge of aortic stents, grafting for abdominal aortic aneurysms and thoracic aneurysms, as well as treating patients with carotid disease," says Jayson Morgan, MD, FACC, Director, Cardiovascular Services. "Dr. Hansen specializes in the comprehensive management of vascular disorders, including open and endovascular surgeries. He is meticulous, thorough, and compassionate in the extraordinary care he provides to patients. We are thrilled that he has joined the Institute for Heart & Vascular Health team at Renown." Dr. Hansen completed his fellowship in Vascular Surgery at the Mayo Clinic in Rochester, MN, and completed his residency in General Surgery at the University of South Carolina, Greenville. He graduated with his Doctor of Medicine from the University of North Carolina School of Medicine, Chapel Hill, and is board certified in both Surgery and Vascular Surgery from the American Board of Surgery and a Fellow of the American College of Surgeons. Dr. Hansen has an interest in complex and acute vascular surgery and is committed to expanding access to qualified vascular care in the region. His mission is to further develop and establish Renown as a premier vascular center in northern Nevada. "Dr. Jaquish has extensive experience in carotid artery disease, carotid endarterectomy, aortic aneurysm and dissection, and peripheral vascular disease," says Sam Obilie-Mante, MBA, MIS, RDCS, RVT, LBBP, VP Administrator, Cardiovascular Services. "Dr. Jaquish is intelligent, professional, conscientious, and always perseveres on behalf of his patients. How proud we are to have him bringing his time and talent to patients across Renown Health." Dr. Jaquish received both his B.S. in Biochemistry (2005), graduating Magna Cum Laude with his Doctor of Medicine (2009) from the University of Nevada, Reno School of Medicine. Dr. Jaquish completed his fellowship in General Surgery at Ascension St. John Hospital and Medical Center in Detroit and a fellowship in Vascular Surgery at Texas A&M at Baylor, Scott & White Hospitals in Temple, TX. He is board certified in both General Surgery and Vascular Surgery. Dr. Jaquish currently serves as Assistant Professor of Clinical Surgery for UNR Med. Dr. Jaquish is bilingual in Spanish, proficient in American Sign Language and serves as an instructor for Advanced Trauma Life Support. Why Vascular and Endovascular Care Matters to You People with complex and serious conditions of the blood vessels and lymph system (vascular diseases) often find the help they need from Renown Health's vascular and endovascular surgical team. Renown's experts provide coordinated and comprehensive treatment to people of all ages. Renown's surgeons use advanced technology to perform vascular and endovascular surgery, including complex stenting procedures, blood clot removal and bypass surgery. Conditions treated include peripheral artery disease, aortic disease, mesenteric disease, nutcracker syndrome and carotid artery disease. "Our expert vascular and endovascular surgeons and staff treat problems that extend from mild to the most critical of emergencies," says Adnan Akbar, MD, Chief Medical Officer for Renown Acute Care. "Specialized physicians including cardiologists, interventional radiologists, heart and vascular surgeons, emergency medicine and trauma surgeons, neurologists, radiologists, physical medicine and rehabilitation specialists, primary care providers, nurses and other clinicians work as a team to determine the best treatment plan for each patient. We encourage all patients to discuss with their primary care providers whether they should undergo formal screening for early vascular disease." "Renown's reputation as the region's vascular and endovascular care leader has been built over many years. We performed the area's first open-heart surgery, angioplasty, stent and valve replacements decades ago. Renown Regional offers incredible advancements like trans-catheter aortic valve replacement (TAVR) and trans-catheter mitral valve repair (TMVr) with MitraClip therapy, lifesaving alternatives to open-heart surgery for patients considered high-risk or inoperable," says Chris Nicholas, FACHE, Chief Executive Officer of Renown Regional Medical Center. "Offering the highest level of comprehensive care for patients experiencing cardiac and vascular disease, Renown developed its first division of cardiothoracic surgery dedicated to heart surgery patients in 2019." The Renown Institute for Heart & Vascular Health program now offers a Diagnostic Electrophysiology Lab; a Chest Pain Center using the D-SPECT® heart camera; multiple Interventional Labs; Heart Failure Program; several Cardiac Catheterization Labs; Interventional Cardiology and Cardiac Surgery when necessary; and the only Pritikin-certified Healthy Heart Program in the West, creating individualized rehabilitation plans tailored to each patient's needs, so they can exercise safely, eat healthy, manage stress and cook nourishing, balanced meals, all while gaining a healthy mindset. In the most recent US News & World Report Best Hospital rankings, Renown Regional Medical Center was named as the number one hospital in Nevada. Ningún otro hospital del estado cumplió con sus estrictos estándares para el ranking de 2021. Renown Health is High Performing, its highest rating possible, in eight procedures and conditions including Heart Failure, Colon Cancer Surgery and Chronic Obstructive Pulmonary Disease, Hip Replacement and Knee Replacement. La calificación de un hospital se basa en múltiples categorías de datos, que incluyen resultados de los pacientes, seguridad y volúmenes. Los hospitales calificados como sobresalientes eran significativamente mejores que el promedio nacional. Las instituciones que componen los rankings de Mejores Hospitales de 2021-22 se seleccionan de entre un conjunto de 4,523 instalaciones, que representan a casi todos los hospitales estadounidenses que brindan atención para pacientes hospitalizados. Los hospitales se evalúan en función de una amplia gama de afecciones y procedimientos, incluidas 16 áreas de especialidad médica. US News & World Report evaluó 58 hospitales en Nevada. Renown Health is Nevada's largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children's hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. Visite renown.org para obtener más información. The University of Nevada, Reno School of Medicine (UNR Med), Nevada's first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

    Read More About Nationally Recognized Vascular Surgeons Join Renown Health

    • Miércoles, 03 de agosto de 2022

    Dr. Max Coppes to Lead William N. Pennington Institute

    Max Coppes, M.D., Ph.D., MBA who has served as Nell J. Redfield Chair of Pediatrics at the University of Nevada School of Medicine (UNR Med) and pediatrician-in-chief at Renown Children’s Hospital for the last six years has announced he is stepping down to lead Renown’s Pennington Cancer Institute on a full-time basis. Dr. Coppes will continue to serve as Professor of Pediatrics and Internal Medicine at UNR Med. “Our goal is to improve the health of Nevadans and reduce the burden of cancer,” said Thomas Graf, CEO of Renown Health. “Having Dr. Coppes as our clinical leader for the William N. Pennington Cancer Institute on a full-time basis reflects Renown and UNR Med’s commitment to increase access to cancer care, foster a deeper partnership with UNR Med on clinical trials, collaborate on cancer research opportunities, and enhance medical education and post-graduate training. We are thrilled to have Dr. Max leading this important effort.” Today’s announcement comes two weeks after the William N. Pennington Foundation announced a $15.5 million gift to the Renown Health Foundation to help establish the William N. Pennington Cancer Institute at Renown. Dr. Coppes, a pediatric oncologist by training, has experience in leading large-scale, nationally recognized academic cancer center teams in both the U.S. and Canada. El Dr. Coppes llegó a Reno en 2014 procedente de la British Columbia Cancer Agency de Vancouver, donde ocupó el cargo de presidente responsable de seis centros oncológicos regionales y dos centros de investigación del cáncer. He was an attending physician at BC Children's Hospital and a professor of Medicine and Pediatrics at the University of British Columbia. During his career, Coppes served as senior vice president at Children's National Medical Center in Washington, D.C. and held positions at several prestigious facilities in the U.S. and Canada including The Hospital for Sick Children (SickKids) in Toronto, Georgetown University, The National Cancer Institute, and the Cleveland Clinic. Since 2016, Dr. Coppes has served in the joint leadership role as the Nell J. Redfield Chair of Pediatrics at UNR Med and pediatrician-in-chief at Renown Children's Hospital, a position made possible through generous philanthropic support from the Nell J. Redfield Foundation along with investments by Renown Health and the School of Medicine. In 2016, the Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. “As the Nell J. Redfield Chair of Pediatrics at the University of Nevada, Reno School of Medicine and pediatrician-in-chief at Renown Children's Hospital, Dr. Coppes blazed the trail for the integration of academic and clinical missions at UNR Med and Renown. He demonstrated visionary leadership and undoubtedly will bring the same energy and vision as the clinical leader for the William N. Pennington Cancer Institute,” said Melissa Piasecki, Acting Dean of UNR Med and Chief Academic Officer for Renown Health. “Dr. Max Coppes is an extraordinary leader. In the last six years he has done much to elevate the standard of pediatric care available in our community,” said Sy Johnson, President and Chief of Staff of Renown. “Thanks to Dr. Coppes’ leadership, the generosity of the Pennington gift and other donors, 100,000 area children now have access to pediatric specialists and contemporary healthcare services at the region’s only children’s hospital. Now, less than 3% of all pediatric patients and their families need to leave the area for specialty care. That is an incredible accomplishment.” Significant achievements made under Dr. Coppes leadership include: Advancing Renown Children’s Hospital, the only dedicated children’s hospital in northern Nevada, offering programs and services for families from a 100,000 square mile area, from Sacramento, CA to Salt Lake City, Utah. Renown Children’s provides the area’s only Children’s Emergency Room, Pediatric ICU (PICU), children’s imaging center and the largest neonatal ICU (NICU), a level III intensive care unit. Under his leadership, the following service lines were established; adolescent medicine, pediatric hematology/oncology, pediatric nephrology, pediatric infectious diseases, pediatric ophthalmology, pediatric orthopedic surgery, pediatric cleft and craniofacial surgery, pediatric urology, pediatric dentistry, and pediatric emergency medicine. Hiring and supporting a team of over 40 pediatric physician specialists. These clinicians provide 30,000 patient visits annually, offering an exceptional level of care to help families. As a testimony to the community’s confidence in the care provided, market share for pediatric services at Renown Health is now close to 90%. Renown’s membership in the Children’s Oncology Group (COG), which gives local pediatric cancer patients access to the world’s largest organization devoted exclusively to childhood cancer and most leading-edge treatments. Application to establish a 3-year accredited (by the Accreditation Council for Graduate Medical Education (ACGME) pediatric residency program in Reno. If approved in September 2022, Renown Health and UNR Med will start training four new pediatricians each year starting in July 2023. Successful application to the Nevada Governor's Office of Science, Innovation & Technology to receive financial support to fund a new Graduate Medical Education program. Renown Children’s Hospital was awarded $ 870,433 for the new pediatric residency program. New construction of an expanded Neonatal Intensive Care Unit (NICU) with increased capacity to 49 bassinets, an expanded Pediatric Intensive Care Unit (PICU) with increased capacity to 16 private patient and family rooms, and a new Renown Children's Hospital in-patient floor with increased capacity for 38 private patient and family rooms for a total capacity of 58 pediatric beds on Level 4 of Renown Regional Medical Center. In 2021, Dr. Coppes was named the Healthcare Hero Community Partner by Northern Nevada Business Magazine.

    Read More About Dr. Max Coppes to Lead William N. Pennington Institute

Número de resultados encontrados: 29
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Página n.º 3 Navegar a la página siguiente Página 1 de 3
Saltee a 29 resultados encontrados. Página 1 de 3